CN103352050A - 利用细菌人工染色体同源重组提高细胞转染效率的方法 - Google Patents
利用细菌人工染色体同源重组提高细胞转染效率的方法 Download PDFInfo
- Publication number
- CN103352050A CN103352050A CN2013102288521A CN201310228852A CN103352050A CN 103352050 A CN103352050 A CN 103352050A CN 2013102288521 A CN2013102288521 A CN 2013102288521A CN 201310228852 A CN201310228852 A CN 201310228852A CN 103352050 A CN103352050 A CN 103352050A
- Authority
- CN
- China
- Prior art keywords
- egfp
- tol2
- bac
- carrier
- plasmid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000001890 transfection Methods 0.000 title claims abstract description 70
- 210000004436 artificial bacterial chromosome Anatomy 0.000 title claims abstract description 69
- 210000004027 cell Anatomy 0.000 title claims abstract description 63
- 238000000034 method Methods 0.000 title claims abstract description 40
- 238000002744 homologous recombination Methods 0.000 title claims abstract description 17
- 230000006801 homologous recombination Effects 0.000 title claims abstract description 17
- 239000013612 plasmid Substances 0.000 claims abstract description 66
- 108090000623 proteins and genes Proteins 0.000 claims abstract description 35
- 239000003550 marker Substances 0.000 claims abstract description 12
- 238000010276 construction Methods 0.000 claims abstract description 11
- 241000124008 Mammalia Species 0.000 claims abstract description 6
- 108020004705 Codon Proteins 0.000 claims abstract description 5
- 241000283707 Capra Species 0.000 claims description 20
- 230000029087 digestion Effects 0.000 claims description 17
- 239000012634 fragment Substances 0.000 claims description 17
- 241000894006 Bacteria Species 0.000 claims description 10
- 230000005611 electricity Effects 0.000 claims description 10
- 238000004043 dyeing Methods 0.000 claims description 9
- 239000013598 vector Substances 0.000 claims description 9
- 238000012408 PCR amplification Methods 0.000 claims description 8
- 230000002068 genetic effect Effects 0.000 claims description 8
- 102000018120 Recombinases Human genes 0.000 claims description 6
- 108010091086 Recombinases Proteins 0.000 claims description 6
- 238000013461 design Methods 0.000 claims description 6
- 239000000284 extract Substances 0.000 claims description 6
- 102000004190 Enzymes Human genes 0.000 claims description 5
- 108090000790 Enzymes Proteins 0.000 claims description 5
- 230000003321 amplification Effects 0.000 claims description 2
- 238000003199 nucleic acid amplification method Methods 0.000 claims description 2
- 239000002773 nucleotide Substances 0.000 claims 1
- 125000003729 nucleotide group Chemical group 0.000 claims 1
- 238000005516 engineering process Methods 0.000 abstract description 7
- 238000012216 screening Methods 0.000 abstract description 5
- 238000002360 preparation method Methods 0.000 abstract description 3
- 241001045988 Neogene Species 0.000 abstract description 2
- 101150091879 neo gene Proteins 0.000 abstract description 2
- 101100315768 Homo sapiens UBC gene Proteins 0.000 abstract 1
- 108010020764 Transposases Proteins 0.000 description 9
- 230000001276 controlling effect Effects 0.000 description 8
- 238000011156 evaluation Methods 0.000 description 8
- 102000008579 Transposases Human genes 0.000 description 6
- 238000000605 extraction Methods 0.000 description 5
- 238000000520 microinjection Methods 0.000 description 5
- 210000004940 nucleus Anatomy 0.000 description 5
- 238000012797 qualification Methods 0.000 description 5
- 230000006798 recombination Effects 0.000 description 5
- 238000005215 recombination Methods 0.000 description 5
- 108020004414 DNA Proteins 0.000 description 4
- 101001007772 Homo sapiens Keratin-associated protein 6-3 Proteins 0.000 description 4
- 101001047413 Homo sapiens Keratin-associated protein 8-1 Proteins 0.000 description 4
- 102100023023 Keratin-associated protein 8-1 Human genes 0.000 description 4
- 230000001580 bacterial effect Effects 0.000 description 4
- 230000006872 improvement Effects 0.000 description 4
- 230000010354 integration Effects 0.000 description 4
- 238000012986 modification Methods 0.000 description 4
- 230000004048 modification Effects 0.000 description 4
- 230000008901 benefit Effects 0.000 description 3
- 101150067309 bmp4 gene Proteins 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- 230000001413 cellular effect Effects 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000003328 fibroblastic effect Effects 0.000 description 3
- 108020004707 nucleic acids Proteins 0.000 description 3
- 102000039446 nucleic acids Human genes 0.000 description 3
- 150000007523 nucleic acids Chemical class 0.000 description 3
- 238000003151 transfection method Methods 0.000 description 3
- 101000911390 Homo sapiens Coagulation factor VIII Proteins 0.000 description 2
- 102100027576 Keratin-associated protein 6-3 Human genes 0.000 description 2
- 238000010367 cloning Methods 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 239000000975 dye Substances 0.000 description 2
- 238000004520 electroporation Methods 0.000 description 2
- 238000012637 gene transfection Methods 0.000 description 2
- 239000005090 green fluorescent protein Substances 0.000 description 2
- 102000057593 human F8 Human genes 0.000 description 2
- 238000011221 initial treatment Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 229940047431 recombinate Drugs 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 230000017105 transposition Effects 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 102100024505 Bone morphogenetic protein 4 Human genes 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 241000252212 Danio rerio Species 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- GDSYPXWUHMRTHT-UHFFFAOYSA-N Epidermin Natural products N#CCC(C)(C)OC1OC(CO)C(O)C(O)C1O GDSYPXWUHMRTHT-UHFFFAOYSA-N 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- 108091029865 Exogenous DNA Proteins 0.000 description 1
- 101000762379 Homo sapiens Bone morphogenetic protein 4 Proteins 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 108020004459 Small interfering RNA Proteins 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 102000004142 Trypsin Human genes 0.000 description 1
- 108090000631 Trypsin Proteins 0.000 description 1
- 238000007664 blowing Methods 0.000 description 1
- 238000004113 cell culture Methods 0.000 description 1
- 230000005779 cell damage Effects 0.000 description 1
- 208000037887 cell injury Diseases 0.000 description 1
- 239000013553 cell monolayer Substances 0.000 description 1
- 210000004748 cultured cell Anatomy 0.000 description 1
- 238000013016 damping Methods 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 108010048367 enhanced green fluorescent protein Proteins 0.000 description 1
- CXTXHTVXPMOOSW-JUEJINBGSA-N epidermin Chemical compound C([C@H]1C(=O)N[C@H](C(=O)N[C@@H](CSC[C@H](C(N[C@@H](CCCCN)C(=O)N1)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)CC)C(=O)N[C@H]1C(N2CCC[C@H]2C(=O)NCC(=O)N[C@@H](CS[C@H]1C)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N\C(=C/C)C(=O)NCC(=O)N[C@H]1C(N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@H]2C(=O)N[C@@H](CC=3C=CC(O)=CC=3)C(=O)N[C@H](C(N\C=C/SC2)=O)CSC1)=O)=O)[C@@H](C)CC)C1=CC=CC=C1 CXTXHTVXPMOOSW-JUEJINBGSA-N 0.000 description 1
- 108010064962 epidermin Proteins 0.000 description 1
- 210000003527 eukaryotic cell Anatomy 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000013613 expression plasmid Substances 0.000 description 1
- 239000013604 expression vector Substances 0.000 description 1
- 230000004992 fission Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 238000013467 fragmentation Methods 0.000 description 1
- 238000006062 fragmentation reaction Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003834 intracellular effect Effects 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 238000002741 site-directed mutagenesis Methods 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 238000011282 treatment Methods 0.000 description 1
- 239000012588 trypsin Substances 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Images
Landscapes
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310228852.1A CN103352050B (zh) | 2013-06-07 | 2013-06-07 | 利用细菌人工染色体同源重组提高细胞转染效率的方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201310228852.1A CN103352050B (zh) | 2013-06-07 | 2013-06-07 | 利用细菌人工染色体同源重组提高细胞转染效率的方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN103352050A true CN103352050A (zh) | 2013-10-16 |
CN103352050B CN103352050B (zh) | 2015-04-15 |
Family
ID=49308461
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201310228852.1A Expired - Fee Related CN103352050B (zh) | 2013-06-07 | 2013-06-07 | 利用细菌人工染色体同源重组提高细胞转染效率的方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN103352050B (zh) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106318965A (zh) * | 2015-06-26 | 2017-01-11 | 深圳华大基因研究院 | 人工半合成染色体的整合方法及含有完整合成染色体的微生物 |
CN108728466A (zh) * | 2018-06-08 | 2018-11-02 | 中国海洋大学 | 一种能够快速获得牙鲆稳转细胞系的载体 |
CN117051039A (zh) * | 2023-07-19 | 2023-11-14 | 中国科学院水生生物研究所 | 两端包含LoxP位点的表达GFP蛋白的质粒及其构建方法和应用 |
-
2013
- 2013-06-07 CN CN201310228852.1A patent/CN103352050B/zh not_active Expired - Fee Related
Non-Patent Citations (2)
Title |
---|
ALEXANDER W BIRD ET AL: "High-efficiency counterselection recombineering for site-directed mutagenesis in bacterial artificial chromosomes.", 《NATURE METHODS 》 * |
JEROEN BUSSMANN AND STEFAN SCHULTE-MERKER: "Rapid BAC selection for tol2-mediated transgenesis in zebrafish.", 《DEVELOPMENT》 * |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN106318965A (zh) * | 2015-06-26 | 2017-01-11 | 深圳华大基因研究院 | 人工半合成染色体的整合方法及含有完整合成染色体的微生物 |
CN106318965B (zh) * | 2015-06-26 | 2019-05-07 | 深圳华大生命科学研究院 | 人工半合成染色体的整合方法及含有完整合成染色体的微生物 |
CN108728466A (zh) * | 2018-06-08 | 2018-11-02 | 中国海洋大学 | 一种能够快速获得牙鲆稳转细胞系的载体 |
CN117051039A (zh) * | 2023-07-19 | 2023-11-14 | 中国科学院水生生物研究所 | 两端包含LoxP位点的表达GFP蛋白的质粒及其构建方法和应用 |
CN117051039B (zh) * | 2023-07-19 | 2024-05-24 | 中国科学院水生生物研究所 | 两端包含LoxP位点的表达GFP蛋白的质粒及其构建方法和应用 |
Also Published As
Publication number | Publication date |
---|---|
CN103352050B (zh) | 2015-04-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105907758B (zh) | CRISPR-Cas9引导序列及其引物、转基因表达载体及其构建方法 | |
CN104651400B (zh) | 一种小鼠Loxl3基因条件性敲除的方法与应用 | |
CN104818253B (zh) | 靶向定点整合cho细胞系的改造及其用途 | |
CN102943092B (zh) | 一种通用型PiggyBac转座子转基因载体及其制备方法 | |
CN105331635A (zh) | 一种诱导型慢病毒表达体系及其构建方法和应用 | |
CN107365803B (zh) | 免药物筛选快速获得小鼠Rosa26基因定点整合外源基因的方法 | |
CN102321655B (zh) | 一种基于假attP位点整合的通用型表达载体及其构建方法和应用 | |
CN108048483B (zh) | 复制型重组腺病毒HAdV-5载体系统及其应用 | |
CN103352050B (zh) | 利用细菌人工染色体同源重组提高细胞转染效率的方法 | |
CN103740756B (zh) | 一种可调控删除的非病毒游离载体及其构建方法 | |
AU778719B2 (en) | Trap vector and gene trapping method by using the same | |
CN101864442A (zh) | 重组火鸡疱疹病毒细菌人工染色体转移载体 | |
CN106399370B (zh) | 一种建立稳定转基因的牙鲆胚胎细胞株方法 | |
CN103923942B (zh) | 一种表达猪端粒酶反转酶转座子载体及其构建方法与在建立猪永生化细胞系中的应用 | |
CN109536463A (zh) | 鸭瘟病毒gE和gI双基因无痕缺失株DPV CHv-ΔgE+ΔgI及其构建方法 | |
CN103160534A (zh) | 一种通用型牛β-酪蛋白位点基因打靶载体及其制备方法 | |
CN102876700A (zh) | PiggyBac转座子介导的肌肉特异表达A-FABP通用载体构建 | |
CN102094036A (zh) | 一种等位基因双敲除打靶载体系统及其构建方法 | |
CN104975043A (zh) | 构建重组mva病毒的带有标记基因自删除系统的穿梭载体 | |
CN108239620A (zh) | IFN-β1编码基因缺失的MDCK细胞株及其构建方法和应用 | |
CN102747102A (zh) | 一种hsa乳腺特异性表达载体及其构建的重组细胞 | |
CN106978416A (zh) | 一种基因定位整合表达系统及其应用 | |
CN105671045A (zh) | 一种提高基因编辑后绵羊胚胎成纤维细胞同源重组修复频率的方法 | |
CN111349616B (zh) | 一种筛选目标病毒相关宿主因子的方法及应用 | |
CN103820494A (zh) | 一种可去除随机整合的位点特异性整合载体及其构建方法和应用 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: HENAN UNIVERSITY Free format text: FORMER OWNER: CAO GENGSHENG Effective date: 20150402 |
|
CB03 | Change of inventor or designer information |
Inventor after: Cao Gengsheng Inventor after: Cao Zhongyang Inventor after: Ruan Weimin Inventor after: Zheng Hexun Inventor before: Cao Zhongyang Inventor before: Ruan Weimin Inventor before: Zheng Hexun |
|
COR | Change of bibliographic data |
Free format text: CORRECT: INVENTOR; FROM: CAO ZHONGYANG RUAN WEIMIN ZHENG HEXUN TO: CAO GENGSHENG CAO ZHONGYANG RUANWEIMIN ZHENG HEXUN |
|
TR01 | Transfer of patent right |
Effective date of registration: 20150402 Address after: 475004 College of life science, Henan University, Kaifeng Road, Kaifeng, Henan Patentee after: Henan University Address before: 475004 School of life sciences, Jinming Road, Kaifeng, Henan Patentee before: Cao Gengsheng |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20150415 Termination date: 20160607 |